A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis

BACKGROUND: Ramucirumab is a monoclonal antibody targeting vascular endothelial growth factor receptor 2 (VEGFR-2). Ramucirumab either alone or in combination with paclitaxel (PTX) has been found to be safe and effective for patients with previously treated advanced gastric cancer. One of the seriou...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Surg Case Rep
Auteurs principaux: Urakawa, Shinya, Sakai, Daisuke, Miyazaki, Yasuhiro, Kudo, Toshihiro, Katou, Aya, Inagaki, Chiaki, Tanaka, Koji, Makino, Tomoki, Takahashi, Tsuyoshi, Kurokawa, Yukinori, Yamasaki, Makoto, Nakajima, Kiyokazu, Takiguchi, Shuji, Satoh, Taroh, Mori, Masaki, Doki, Yuichiro
Format: Artigo
Langue:Inglês
Publié: Springer Berlin Heidelberg 2017
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5736507/
https://ncbi.nlm.nih.gov/pubmed/29260338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-017-0399-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires